Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casdatifan PK in Moderate Hepatic Impairment
NCT07751250Phase 1Recruiting
- Sponsor
- Arcus Biosciences
- Start
- Aug 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of casdatifan (2 arms), sponsored by Arcus Biosciences. Primary endpoints: Area under the concentration time curve, from time 0 to the last observed non-zero concentration, Area under the concentration time curve from time 0 extrapolated to infinity and 1 more. Started Aug 2026; status: recruiting.
02
Drugs
casdatifan
Beyond the preview
Go deeper on NCT07751250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07751250.